Will Fortune Favor The Brave? Biosimilar Sponsors Need High Tolerance For Uncertainty
Executive Summary
Regulatory framework for biosimilars is still a work in progress, especially on the analytical and labeling issues that featured in the Pink Sheet's Drug Review Profile of Zarxio.